MAGEC2 antibody

Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
MAGEC2 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab04944
tested applications
ELISA, IHC
Description
Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and stimulates p53/TP53 ubiquitination in presence of Ubl-conjugating enzyme UBE2H leading to p53/TP53 degradation. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzymes(E2) at the E3:substrate complex.
Documents del producto
Product specifications
| Category | Primary Antibodies  | 
| Immunogen Target | melanoma antigen family C, 2 (MAGEC2)  | 
| Host | Rabbit  | 
| Reactivity | Human  | 
| Recommended Dilution | IHC: 1:20 - 1:200  | 
| Clonality | polyclonal  | 
| Conjugation | Unconjugated  | 
| Isotype | IgG  | 
| Observed MW | 41 kDa  | 
| Purity | ≥95% as determined by SDS-PAGE  | 
| Purification | Immunogen affinity purified  | 
| Size 1 | 100µg  | 
| Form | liquid  | 
| Tested Applications | ELISA, IHC  | 
| Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)  | 
| UniProt ID | Q9UBF1  | 
| Gene ID | 51438  | 
| Alias | Melanoma-associated antigen C2,Cancer/testis antigen 10 (CT10),Hepatocellular carcinoma-associated antigen 587,MAGE-C2 antigen,MAGE-E1 antigen,MAGEC2,HCA587,MAGEE1  | 
| Background | Antibody anti-MAGEC2  | 
| Status | RUO  | 
| Note | Mol. Weight 41 kDa  | 
Descripción
Related Products

Human MAGEC2 (Melanoma-associated antigen C2) ELISA Kit
Ver Producto
MAGEC2 antibody
Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and stimulates p53/TP53 ubiquitination in presence of Ubl-conjugating enzyme UBE2H leading to p53/TP53 degradation. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzymes(E2) at the E3:substrate complex.
Ver Producto